LifeStance Health Group (NASDAQ:LFST) Earns Buy Rating from Analysts at Canaccord Genuity Group
Analysts at Canaccord Genuity Group began coverage on shares of LifeStance Health Group (NASDAQ:LFST – Get Free Report) in a research report issued to clients and investors on Thursday, MarketBeat reports. The firm set a “buy” rating and a $8.00 price target on the stock. Canaccord Genuity Group’s target price would indicate a potential upside […]
Analysts at Canaccord Genuity Group began coverage on shares of LifeStance Health Group (NASDAQ:LFST – Get Free Report) in a research report issued to clients and investors on Thursday, MarketBeat reports. The firm set a “buy” rating and a $8.00 price target on the stock. Canaccord Genuity Group’s target price would indicate a potential upside […]
